Physician profile
John E Lindsay
NPI 1245444819
$3,882.12
in general payments reported to CMS, 2019-2025
15 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.92 · 2023: $311 · 2024: $3,332 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,992 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,992.00 |
| Food and Beverage | $841.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $2,992.00 | 2024 | |
| Djo, LLC | $135.18 | 2024 | Cmf |
| Treace Medical Concepts, INC. | $133.51 | 2023-2025 | |
| Organogenesis INC. | $124.86 | 2022-2025 | Puraply, Cygnus Dual, Apligraf |
| Smith+Nephew, INC. | $76.98 | 2023-2024 | Stravix Pl, Grafix Pl |
| Stryker Corporation | $76.96 | 2022-2023 | 7 X 23mm Citrelock Implant |
| Medtronic, INC. | $62.44 | 2023-2025 | Inceptiv, Intellis Adaptivestim, Vanta Adaptivestim |
| Averitas Pharma INC. | $60.40 | 2024 | Qutenza |
| Polynovo North America LLC | $47.78 | 2024 | Novosorb Btm |
| Paragon 28, INC. | $44.70 | 2022-2023 | Phantom Metatarsal Shortening |
| Integra Lifesciences Corporation | $39.70 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Next Science LLC | $32.81 | 2023 | Surgx, Xperience, Blastx |
| Axogen | $21.46 | 2023 | Avance Nerve Graft |
| Elite Orthopedics, LLC | $18.38 | 2023 | |
| Ebi, LLC | $14.96 | 2025 | Biomet Ebi Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lindsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.